One surgical working element for both bipolar and laser prostate enucleation.

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, single-center feasibility project will observe men with BPH and prostate volume ≥40 cc who are scheduled for enucleation to see how a single interchangeable working element performs with both bipolar and laser energy. Surgeons will use the same working element during bipolar and laser enucleation procedures while investigators record intraoperative events, device performance, and immediate safety outcomes. The study excludes men with active urinary infections, prior prostate surgery, coagulation disorders, long-term anticoagulation, known urethral strictures, or prostate cancer. No randomization or therapeutic comparison is planned; the primary focus is real-time feasibility and safety signals to inform later trials.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed with benign prostatic hyperplasia (BPH) requiring surgical intervention.
* Prostate volume ≥40 cc (as assessed by transrectal ultrasound).
* No prior history of prostate cancer.

Exclusion Criteria:

* Patients with ongoing urinary tract infections.
* Prior prostate surgeries.
* Coagulation disorders or patients on long-term anticoagulation therapy.
* Known urethral strictures or other anatomical abnormalities complicating endoscopic procedures.

Where it's running

• Menoufia Faculty of Medicine
  Shibīn al Kawm, Menoufia, Egypt Recruiting

Study contacts

• Study coordinator: Mohamed K Omar, Assistant professor
• Email: kimo_81eg@yahoo.com
• Phone: +201066949454

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• See if PuraStat after Aquablation reduces bleeding and speeds discharge

  This study tests whether applying PuraStat after Aquablation can reduce bleeding and allow more patients to go home the same day.

  Recruiting Endeavor Health · Glenview, Illinois · NCT07789041

• Transurethral Thermodilatation vs Prostatic Urethral Lift for BPH in men 50–80

  This study tests whether Prolieve can match UroLift in relieving BPH symptoms in men 50–80 who haven’t had enough relief from medicines.

  Recruiting The University of Hong Kong · Hong Kong · NCT07759752

• Sonablate HIFU Registry for Prostate Cancer and BPH

  This registry collects real-world data from men treated with Sonablate HIFU to see how well it works and how it affects urinary and sexual function over the long term.

  Recruiting Sonablate · Indianapolis, Indiana · NCT07757490

• Beacon Platform for HoLEP: Safer, Smarter Prostate Surgery

  This trial tests whether the Beacon Platform can safely support the HoLEP procedure for men with enlarged prostates.

  Recruiting at 5 sites Andromeda Surgical · Sofia and 4 other locations · NCT07741656

• Veloxion disposable resectoscope system for BPH surgery

  This study tests whether the Veloxion disposable resectoscope helps perform endoscopic BPH surgery more efficiently and safely in men with moderate to large prostates.

  Recruiting Chinese University of Hong Kong · Shatin · NCT07728071

• Ultra-minimally invasive prostate balloon dilation for men with BPH and significant obstruction

  This study tests whether transrectal ultrasound–guided ultra-minimally invasive prostate balloon dilation can reduce urinary symptoms in men aged 40–80 with BPH and significant bladder outlet obstruction.

  Recruiting Chinese PLA General Hospital · Beijing · NCT07583706

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.